A biocomputer powered by lab-grown human brain cells has leveled up from Pong to Doom. While nowhere ready to handle the video game shooter’s most challenging levels, researchers at Cortical Labs in ...

This article explores multiplexing applications in biopharma and highlights key assay development factors to consider.

When the performance of AI models was assessed within stratified patient subgroups, such as only high-grade breast cancers or only MSI-positive tumors, accuracy fell substantially, revealing that the ...

Delve into the field of pulmonary hypertension as GSK places a $950M bet on 35Pharma's candidate HS235 following the footsteps of Winrevair.

MOFs look stable in the lab, but living systems tell a different story. Why ‘stable’ materials can break down in bodies, with hidden risks ...

Mechanisms and Frontiers of Treatment for Diabetes-Related Epilepsy. Journal of Biosciences and Medicines, 14, 57-73. doi: 10.4236/jbm.2026.143006 . Diabetes mellitus (DM) is a metabolic disease ...

What follows is an accounting of what actually happened when intelligence became abundant. Not because the technology underperformed, but because humans are resilient.

PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / March 2, 2026 / Prolocor, Inc., a healthcare company developing the innovative diagnostic Prolocor pFCG™ test to identify patients at risk of thrombotic ...

VTT's second independent test shows Donut Lab's solid-state cell delivered 110% capacity at 80°C and survived 100°C discharge ...

This important study implicates that changes in cell regulation may contribute to the evolution of multicellularity. The evidence supporting the conclusions is convincing, with rigorous methods used ...

The American Red Cross is urging donors to help the national blood supply recover from a severe blood shortage and empower ...

Before we move into the 2025 results presentation, I'd like to begin by marking an important moment in the evolution of Oxford Nanopore. As previously announced, today, Gordon Sanghera steps down as ...